INOVIO PHARMACEUTICALS, INC. (INO) Shareholders’ equity 2016–2025
INOVIO PHARMACEUTICALS, INC. (INO) shareholders’ equity at each fiscal year-end, per SEC filings.
$24.1MFY2025 · since FY2016: $123.3M → $24.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $24.1M | -64.8% |
| FY2024 | $68.5M | -41.6% |
| FY2023 | $117.3M | -47.2% |
| FY2022 | $222.4M | -44.4% |
| FY2021 | $399.7M | -13.3% |
| FY2020 | $461.1M | +13324.4% |
| FY2019 | $3.4M | -96.0% |
| FY2018 | $86.9M | -38.9% |
| FY2017 | $142.4M | +15.5% |
| FY2016 | $123.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice